A detailed history of Gagnon Securities LLC transactions in Profound Medical Corp. stock. As of the latest transaction made, Gagnon Securities LLC holds 1,467,247 shares of PROF stock, worth $11 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares
1,467,247
Previous 1,508,521 2.74%
Holding current value
$11 Million
Previous $12.7 Million 7.72%
% of portfolio
2.46%
Previous 2.99%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$7.47 - $11.18 $308,316 - $461,443
-41,274 Reduced 2.74%
1,467,247 $11.7 Million
Q2 2024

Aug 14, 2024

SELL
$7.25 - $9.07 $148,741 - $186,080
-20,516 Reduced 1.34%
1,508,521 $12.7 Million
Q1 2024

May 13, 2024

SELL
$7.3 - $9.46 $91,534 - $118,618
-12,539 Reduced 0.81%
1,529,037 $13 Million
Q4 2023

Feb 14, 2024

SELL
$7.85 - $11.18 $318,631 - $453,796
-40,590 Reduced 2.57%
1,541,576 $13.1 Million
Q3 2023

Nov 14, 2023

SELL
$7.91 - $13.27 $181,724 - $304,864
-22,974 Reduced 1.43%
1,582,166 $16.1 Million
Q2 2023

Aug 08, 2023

SELL
$9.27 - $14.88 $1.07 Million - $1.72 Million
-115,424 Reduced 6.71%
1,605,140 $20.9 Million
Q1 2023

Apr 10, 2023

SELL
$8.85 - $13.27 $510,122 - $764,896
-57,641 Reduced 3.24%
1,720,564 $16 Million
Q4 2022

Feb 07, 2023

BUY
$3.18 - $10.91 $36,093 - $123,828
11,350 Added 0.64%
1,778,205 $19.4 Million
Q3 2022

Nov 14, 2022

BUY
$3.99 - $9.3 $1.75 Million - $4.09 Million
439,323 Added 33.09%
1,766,855 $7.13 Million
Q2 2022

Aug 01, 2022

BUY
$6.34 - $9.53 $20,268 - $30,467
3,197 Added 0.24%
1,327,532 $9.68 Million
Q1 2022

May 09, 2022

BUY
$8.16 - $11.33 $2.02 Million - $2.8 Million
246,978 Added 22.92%
1,324,335 $11.9 Million
Q4 2021

Feb 08, 2022

BUY
$10.38 - $15.2 $11.2 Million - $16.4 Million
1,077,357 New
1,077,357 $12.1 Million
Q3 2021

Nov 12, 2021

SELL
$13.6 - $17.88 $10.9 Million - $14.3 Million
-800,845 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$16.0 - $20.59 $367,280 - $472,643
22,955 Added 2.95%
800,845 $13.1 Million
Q1 2021

May 14, 2021

SELL
$19.16 - $28.09 $829,742 - $1.22 Million
-43,306 Reduced 5.27%
777,890 $15.7 Million
Q4 2020

Feb 12, 2021

BUY
$16.4 - $22.9 $683,273 - $954,082
41,663 Added 5.34%
821,196 $16.9 Million
Q3 2020

Nov 12, 2020

BUY
$14.05 - $18.13 $671,842 - $866,940
47,818 Added 6.54%
779,533 $13.8 Million
Q2 2020

Aug 13, 2020

SELL
$9.41 - $16.94 $340,745 - $613,414
-36,211 Reduced 4.72%
731,715 $12.4 Million
Q1 2020

May 11, 2020

BUY
$6.88 - $19.7 $489,278 - $1.4 Million
71,116 Added 10.21%
767,926 $7.48 Million
Q4 2019

Feb 14, 2020

BUY
$6.4 - $11.95 $4.46 Million - $8.33 Million
696,810 New
696,810 $7.63 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Gagnon Securities LLC Portfolio

Follow Gagnon Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.